Skip to main content
Caplight Logo









Rejoni, Inc.

Rejoni, Inc.

Private
Bedford, MassachusettsHealthcare & Life Scienceshttps://rejoni.com/

Last Round

VC Round

Jun 16, 2026

Total Funding Raised

$40M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Rejoni, Inc. is a medical device company that develops and commercializes gynecological products using proprietary biomaterials to improve outcomes in minimally invasive surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biomaterialshydrogelsurgical adhesion preventionmedical devicesoft tissue repairabsorbable biomaterialsmedtechclinical trialsgynecological surgerybiotechFDA clearancesurgical barrierreconstructive surgerybiomaterial barrier

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rejoni, Inc. Comparables

Compare Rejoni, Inc. with similar companies based on industry and business-model similarity.

Rejoni, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FzioMed, Inc.
81%
Womed
77%
Anika Therapeutics
77%

Rejoni, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 16, 2026
Series BDec 7, 2022
Series ASep 14, 2020

Key People

Founding team and executive leadership

John Nealon

President, CEO & Board Director

Executive Team

Rejoni, Inc. Investors

Notable investors and investment history

Rejoni, Inc. investors
InvestorRounds
Ascension VenturesSeries A
Sparta Group LLCSeries B, Series A, VC Round
ClavystBioVC Round
Catalyst Health VenturesVC Round, Series B
FemHealth VenturesVC Round
Delos Capital PartnersSeries B, Series A, VC Round
AMED VenturesSeries B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 2247% MoM, from 38 to 892.

  • Jul 23, 2026

    Grew 24% QoQ from 17 to 21 employees.

Rejoni, Inc. Filings

Explore SEC and related filing metadata, where available.

Rejoni, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rejoni, Inc.'s valuation, stock price, and market status.

Is Rejoni a public or private company?

Rejoni is a private company.

What is the current stock price of Rejoni?

Rejoni is a private company with no public stock price. No recent secondary market data is available.

How much is Rejoni worth (valuation)?

Valuation information for Rejoni is not publicly available.

Can I buy Rejoni stock?

Rejoni shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rejoni's last funding round?

Rejoni's most recent funding round was Early Funding on June 16, 2026.

Who are the main investors in Rejoni?

Key investors in Rejoni include Ascension Ventures, Catalyst Health Ventures.

Will Rejoni IPO soon?

No public IPO plans have been announced for Rejoni.

How can I track Rejoni secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rejoni's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBedford, Massachusetts
Employee Range16
Year Founded2020
Last FundingJun 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?